| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution (NCT00643994) | Accuray Incorporated | 2007-12-01 |
| Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer (NCT00619515) | Case Comprehensive Cancer Center | 2007-12-01 |
| Efficacy Study of ABR-215050 to Treat Prostate Cancer (NCT00560482) | Active Biotech AB | 2007-12-01 |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery (NCT00977457) | City of Hope Medical Center | 2007-11-26 |
| Quality of Life Study for Prostate Cancer Patients (NCT00561444) | M.D. Anderson Cancer Center | 2007-11-14 |
| A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer (NCT00564928) | Infinity Pharmaceuticals, Inc. | 2007-11-01 |
| RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery (NCT00541047) | University College, London | 2007-11-01 |
| Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer (NCT00637208) | Maaynei Hayesha Medical Center | 2007-11-01 |
| PCMRI - an MRI/TRUS System for the Evaluation of the Prostate (NCT00542100) | TopSpin Medical | 2007-11-01 |
| A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer (NCT00557037) | MEI Pharma, Inc. | 2007-11-01 |
| Internal Radiation Therapy in Treating Patients With Prostate Cancer (NCT00573833) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases (NCT00554229) | AstraZeneca | 2007-11-01 |
| Effect of Lap-Band Induced Weight Loss on Serum PSA Levels (NCT00562341) | Maimonides Medical Center | 2007-11-01 |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry (NCT00643617) | Accuray Incorporated | 2007-10-22 |
| Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses (NCT00536055) | Tel-Aviv Sourasky Medical Center | 2007-10-01 |
| Global Performance Evaluation of the AMS CONTINUUM™ Device (NCT01083199) | American Medical Systems | 2007-10-01 |
| Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel (NCT00499694) | Barbara Ann Karmanos Cancer Institute | 2007-10-01 |
| A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment (NCT00823771) | Barwon Health | 2007-10-01 |
| Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation (NCT00541788) | University Hospital, Ghent | 2007-10-01 |
| Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. (NCT01045109) | Medical University of South Carolina | 2007-10-01 |
| FACBC PET/CT for Recurrent Prostate Cancer (NCT00562315) | David M. Schuster, MD | 2007-10-01 |
| Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy (NCT00559481) | Roswell Park Cancer Institute | 2007-10-01 |
| Sutent Maintenance After Response to Taxotere (NCT00550810) | Alberta Health services | 2007-10-01 |
| Internet-Based Education for Prostate Cancer Screening (NCT00623090) | Georgetown University | 2007-10-01 |
| Vitamin D for Chemoprevention (NCT00585637) | Dana-Farber Cancer Institute | 2007-10-01 |
| 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer (NCT01653093) | University of Cincinnati | 2007-09-20 |
| Hypo-fractionated Postoperative IMRT in Prostate Cancer (NCT03233672) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2007-09-18 |
| Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate (NCT00691977) | Virginia Commonwealth University | 2007-09-01 |
| Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery (NCT00685516) | Jonsson Comprehensive Cancer Center | 2007-09-01 |
| Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors (NCT00738140) | Massachusetts General Hospital | 2007-09-01 |
| USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases (NCT00622973) | Insel Gruppe AG, University Hospital Bern | 2007-09-01 |
| Bone Health Observational Study (NCT00632905) | CMX Research | 2007-09-01 |
| Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00176631) | Rutgers, The State University of New Jersey | 2007-09-01 |
| AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer (NCT00519233) | Astellas Pharma Inc | 2007-09-01 |
| Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer (NCT00526591) | Jorge A. Garcia, MD | 2007-09-01 |
| Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer (NCT00668083) | AstraZeneca | 2007-09-01 |
| Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy (NCT03211104) | Samsung Medical Center | 2007-08-30 |
| Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy (NCT00526331) | M.D. Anderson Cancer Center | 2007-08-01 |
| Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody (NCT00538668) | Weill Medical College of Cornell University | 2007-08-01 |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient (NCT00544336) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Early Detection of Prostate Cancer by FACS (NCT00524823) | Ziv Hospital | 2007-08-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy (NCT00589420) | Abramson Cancer Center at Penn Medicine | 2007-07-27 |
| A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer (NCT00510718) | Pfizer | 2007-07-23 |
| CHESS: Human and Computer Mentors for Prostate Cancer Patients (NCT00516256) | M.D. Anderson Cancer Center | 2007-07-03 |
| Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer (NCT00570700) | University of California, Irvine | 2007-07-01 |
| High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer (NCT00561314) | University College London Hospitals | 2007-07-01 |
| The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer (NCT00496249) | University Health Network, Toronto | 2007-07-01 |
| Blood Test to Measure DNA Damage in Blood (NCT00523471) | AHS Cancer Control Alberta | 2007-07-01 |
| Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy (NCT00513721) | Corewell Health East | 2007-07-01 |
| Sandostatin for Patients With Androgen Independent Prostate Cancer (NCT00510224) | University of California, San Francisco | 2007-07-01 |
| Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer (NCT00515112) | University of Chicago | 2007-07-01 |
| Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies (NCT01827813) | TC Erciyes University | 2007-06-01 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) (NCT00539968) | Merck Sharp & Dohme LLC | 2007-06-01 |
| Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy (NCT00462124) | BioProtect | 2007-06-01 |
| Image Guided Radiation Therapy For Prostate Cancer (NCT00433706) | Gustave Roussy, Cancer Campus, Grand Paris | 2007-06-01 |
| Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? (NCT00982800) | Sunnybrook Health Sciences Centre | 2007-06-01 |
| Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients (NCT00901420) | M.D. Anderson Cancer Center | 2007-06-01 |
| An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy (NCT00485303) | Cougar Biotechnology, Inc. | 2007-06-01 |
| Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients (NCT00433797) | University of Oslo | 2007-06-01 |
| Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression (NCT00446901) | Wageningen University | 2007-06-01 |
| Micro-RNA Expression Profiles in High Risk Prostate Cancer (NCT01220427) | Wuerzburg University Hospital | 2007-06-01 |
| Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT) (NCT00635167) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2007-06-01 |
| Vitamin D in Treating Patients With Prostate Cancer (NCT00524680) | Roswell Park Cancer Institute | 2007-06-01 |
| A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients (NCT00466440) | Eli Lilly and Company | 2007-06-01 |
| Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer (NCT00430183) | Alliance for Clinical Trials in Oncology | 2007-05-08 |
| A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen (NCT00623831) | Ludwig Institute for Cancer Research | 2007-05-01 |
| Early Assessment of Treatment Response Using Functional Diffusion Mapping (NCT02064283) | University of Michigan Rogel Cancer Center | 2007-05-01 |
| Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy (NCT00653848) | Scandinavian Prostate Cancer Group | 2007-05-01 |
| Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners (NCT00503646) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy (NCT00468286) | Ferring Pharmaceuticals | 2007-05-01 |
| A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients (NCT00503984) | University of Miami | 2007-05-01 |
| An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors (NCT00514267) | Astellas Pharma Inc | 2007-05-01 |
| Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy (NCT00450411) | Radiation Therapy Oncology Group | 2007-05-01 |
| Pain in Cancer Survivors (NCT00581724) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| Prostate Biomarker Study (NCT00574899) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| Coping in African American Prostate Cancer Survivors (NCT00589966) | Duke University | 2007-05-01 |
| A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence (NCT00480623) | Agennix | 2007-05-01 |
| Docetaxel in Treating Patients With Relapsed Prostate Cancer (NCT00482274) | OHSU Knight Cancer Institute | 2007-05-01 |
| Vinflunine in Hormone Refractory Prostate Cancer (HRPC) (NCT00545766) | SCRI Development Innovations, LLC | 2007-05-01 |
| Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts (NCT00523484) | AstraZeneca | 2007-05-01 |
| S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00433446) | SWOG Cancer Research Network | 2007-04-01 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer (NCT00499408) | Wake Forest University Health Sciences | 2007-04-01 |
| Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy (NCT00439751) | Ontario Clinical Oncology Group (OCOG) | 2007-04-01 |
| Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer (NCT00598312) | Oakwood Laboratories, LLC | 2007-04-01 |
| A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer (NCT00480090) | University Health Network, Toronto | 2007-04-01 |
| Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury (NCT00580970) | Virginia Commonwealth University | 2007-04-01 |
| Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer (NCT00770822) | SonaCare Medical | 2007-04-01 |
| Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) (NCT00488982) | University of California, San Francisco | 2007-04-01 |
| Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners (NCT00483678) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. (NCT00565227) | University of Michigan Rogel Cancer Center | 2007-04-01 |
| Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia (NCT00780754) | Kaunas University of Medicine | 2007-04-01 |
| Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer (NCT00514072) | Kael-GemVax Co., Ltd. | 2007-03-01 |
| A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy (NCT00451958) | Ferring Pharmaceuticals | 2007-03-01 |
| Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities (NCT00453661) | M.D. Anderson Cancer Center | 2007-03-01 |
| Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy (NCT00480857) | University of Michigan Rogel Cancer Center | 2007-03-01 |
| Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer (NCT00619996) | Italian Trial in Medical Oncology | 2007-03-01 |
| 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate (NCT00464724) | M.D. Anderson Cancer Center | 2007-03-01 |
| Intensity Modulated Versus Interstitial - Radiation Therapy (NCT00407875) | British Columbia Cancer Agency | 2007-03-01 |